-The Hindu TV commercial on GlaxoSmithKline’s vaccine against Rota virus makes unsubstantiated claims, says ASCI At a time when the commercial interests of major private hospitals or pharma giants often take precedence over the health concerns of the common man, a New Delhi doctor has managed to get the Advertising Standards Council of India to stall a television commercial, aired by GlaxoSmithKline Pharmaceuticals, hailing the benefits of its vaccine against Rota virus. The...

-The Telegraph A children’s vaccine against a stomach infection has triggered controversy with some doctors claiming there is not enough data to show it is effective in India and accusing a leading drug company of using a misleading advertisement to promote the vaccine. GlaxoSmithKline Pharmaceuticals (GSK) has stopped the advertisement for the vaccine intended to protect children from potentially life-threatening rotavirus infections after the advertising industry’s self-regulating body upheld a doctor’s complaint...

-The Hindu India’s drug price control order, which is vital to the availability of affordable essential medicines, has been whittled down to the point of becoming insignificant. While the number of price-controlled medicines has dwindled over the past three decades, from 347 to 74, the pharmaceutical industry has been pursuing super profits. The High Level Expert Group of the Planning Commission on Universal Health Coverage noted in its report that price...

-The Economic Times The Union Cabinet has okayed a new price-control formula for pharmaceuticals, which seeks to cap prices at the arithmetic average of all drugs with more than 1% market share in any therapeutic segment that is to be brought under price control. Given that the existing system of fixing prices of select drugs is on the basis of costs, which is rigid, intrusive and prone to manipulation as well,...

-The Times of India A once-a-week medicine for diabetics — a disease that affects nearly 63 million Indians — could soon become a reality. Studies on diabetes have seen a global upsurge, with the latest data showing that bio-pharmaceutical research companies across the globe are busy developing 221 innovative new medicines. The drugs, which will help around 347 million patients include new therapies that target key abnormalities of pancreatic cells, increase insulin secretion...